Claims
- 1. A method of modulating the fertility of a plant comprising treating said plant with GABA or a GABA analog.
- 2. The method of claim 1, wherein the GABA analog is selected from the group consisting of forskolin, gabapentin and pregabalin, 4-cis-aminocrotonic acid, N-methyl-Exo-THPO, Tetrahydroisoxazolo pyridin (THIP), Imidazole-4-acetic acid, Isoguvacine, Muscimol, Baclofen, Cis-aminocrotonic acid (CACA) and Trans-aminocrotonic acid (TACA).
- 3. The method of claim 1, wherein the plant is a monoecious plant.
- 4. The method of claim 3, further defined as a method of creating a male sterile plant, wherein treating said plant comprises treating the male portion of flowers on said plant.
- 5. The method of claim 1, wherein said modulating comprises rendering said plant sterile.
- 6. The method of claim 5, wherein said modulating comprises rendering said plant self-sterile.
- 7. The method of claim 1, wherein the plant is a dicotyledonous plant.
- 8. The method of claim 7, wherein the dicotyledonous plant is selected from the group consisting of tobacco, tomato, potato, sugar beet, pea, carrot, cauliflower, broccoli, soybean, canola, sunflower, alfalfa, and cotton.
- 9. The method of claim 7, wherein the dicotyledonous plant is Arabidopsis thaliana.
- 10. The method of claim 1, wherein the plant is a monocotyledonous plant.
- 11. The method of claim 10, wherein said monocotyledonous plant is selected from the group consisting of wheat, maize, rye, rice, turfgrass, oat, barley, sorghum, millet, and sugarcane.
- 12. The method of claim 1, wherein treating comprises treating a flower on the plant.
- 13. The method of claim 1, wherein treating comprises an over the top application of the GABA or GABA analog.
- 14. A method of modulating the fertility of a plant comprising treating said plant with a GABA transaminase inhibitor.
- 15. The method of claim 14, wherein the GABA transaminase inhibitor is selected from the group consisting of (S)-4-Amino-5-fluoropentanoic Acid, 4-Amino-2-(substituted methyl)-2-butenoic Acids, 4-Amino-5-fluoropent-2-enoic Acid, gamma-vinyl GABA [D,L-4-amino-hex-5-enoic acid (Vigabatrin®))] and Valproate.
- 16. The method of claim 14, wherein the plant is a monoecious plant.
- 17. The method of claim 14, further defined as a method of creating a male sterile plant, wherein treating said plant comprises treating the male portion of flowers on the plant.
- 18. The method of claim 14, wherein said modulating comprises rendering said plant self-sterile.
- 19. The method of claim 14, wherein the plant is a dicotyledonous plant.
- 20. The method of claim 19, wherein the dicotyledonous plant is selected from the group consisting of tobacco, tomato, potato, sugar beet, pea, carrot, cauliflower, broccoli, soybean, canola, sunflower, alfalfa, and cotton.
- 21. The method of claim 19, wherein the dicotyledonous plant is Arabidopsis thaliana.
- 22. The method of claim 14, wherein the plant is a monocotyledonous plant.
- 23. The method of claim 22, wherein said monocotyledonous plant is selected from the group consisting of wheat, maize, rye, rice, turfgrass, oat, barley, sorghum, millet, and sugarcane.
- 24. The method of claim 14, wherein treating comprises applying the GABA transaminase inhibitor to a flower.
- 25. The method of claim 14, wherein treating comprises an over the top application of the GABA transaminase inhibitor.
- 26. A method of restoring the fertility of a plant having flowers rendered self-sterile by elevated GABA levels comprising treating said plant with a GABA inhibitor.
- 27. The method of claim 26, wherein the GABA inhibitor is selected from the group consisting of guvacine, (R)-nipecotic acid, Tiagabine, anticonvulsant 1-(2-(((diphenylmethylene)amino)oxy)ethyl)-1,2,5, 6-tetrahydro pyridinecarboxylic acid hydrochloride, NNC-71 1, Bicuculline, Pitrazepin, Benzyl penicillin, securinine, Phaclofen, CGP35348, Picrotoxin, 1,2,5,6-tetrahydopyridine-4-yl, and methylphophinic acid.
- 28. The method of claim 26, wherein the plant is further defined as comprising a mutated POP2 gene.
- 29. The method of claim 26, wherein the plant comprises a transgenic antisense POP2 gene.
- 30. The method of claim 26, wherein the plant is a dicotyledonous plant.
- 31. The method of claim 30, wherein the dicotyledonous plant is Arabidopsis thaliana.
- 32. The method of claim 30, wherein the dicotyledonous plant is selected from the group consisting of tobacco, tomato, potato, sugar beet, pea, carrot, cauliflower, broccoli, soybean, canola, sunflower, alfalfa, and cotton.
- 33. The method of claim 26, wherein the plant is a monocotyledonous plant.
- 34. The method of claim 33, wherein said monocotyledonous plant is selected from the group consisting of wheat, maize, rye, rice, turfgrass, oat, barley, sorghum, millet, and sugarcane.
- 35. The method of claim 26, wherein treating comprises applying the GABA inhibitor to a flower.
- 36. The method of claim 26, wherein treating comprises an over the top application of the GABA inhibitor.
- 37. A method of plant breeding comprising:
a) obtaining first and second plants; b) treating said first plant with GABA or a GABA analog; and c) pollinating the first plant with pollen from said second plant.
- 38. The method of claim 37, wherein pollinating comprises allowing natural pollination to occur.
- 39. The method of claim 37, wherein pollination comprises manual pollination.
- 40. The method of claim 37, wherein the first plant is rendered self-sterile following said treating.
- 41. The method of claim 37, wherein the GABA analog is selected from the group consisting of forskolin, gabapentin and pregabalin, 4-cis-aminocrotonic acid, N-methyl-Exo-THPO, Tetrahydroisoxazolo pyridin (THIP), Imidazole-4-acetic acid, Isoguvacine, Muscimol, Baclofen,Cis-aminocrotonic acid (CACA) and Trans-aminocrotonic acid (TACA).
- 42. The method of claim 37, wherein the first and second plants are dicotyledonous plants.
- 43. The method of claim 42, wherein the dicotyledonous plants are Arabidopsis thaliana plants.
- 44. The method of claim 42, wherein the dicotyledonous plants are plants selected from the group consisting of tobacco, tomato, potato, sugar beet, pea, carrot, cauliflower, broccoli, soybean, canola, sunflower, alfalfa, and cotton.
- 45. The method of claim 37, wherein the first and second plants are monocotyledonous plants.
- 46. The method of claim 45, wherein the monocotyledonous plants are selected from the group consisting of wheat, maize, rye, rice, turfgrass, oat, barley, sorghum, millet, and sugarcane.
- 47. A method of plant breeding comprising:
a) obtaining first and second plants; b) treating said first plant with a GABA transaminase inhibitor; and c) pollinating the first plant with pollen from said second plant.
- 48. The method of claim 47, wherein pollinating comprises allowing natural pollination to occur.
- 49. The method of claim 47, wherein pollination comprises manual pollination.
- 50. The method of claim 47, wherein the first plant is rendered self-sterile following said treating.
- 51. The method of claim 47, wherein the GABA transaminase inhibitor is selected from the group consisting of (S)-4-Amino-5-fluoropentanoic Acid, 4-Amino-2-(substituted methyl)-2-butenoic Acids, 4-Amino-5-fluoropent-2-enoic Acid, gamma-vinyl GABA [D,L-4-amino-hex-5-enoic acid (Vigabatrin®))] and Valproate.
- 52. The method of claim 47, wherein the first and second plants are dicotyledonous plants.
- 53. The method of claim 52, wherein the dicotyledonous plants are Arabidopsis thaliana plants.
- 54. The method of claim 52, wherein the dicotyledonous plants are plants selected from the group consisting of tobacco, tomato, potato, sugar beet, pea, carrot, cauliflower, broccoli, soybean, canola, sunflower, alfalfa, and cotton.
- 55. The method of claim 47, wherein the first and second plants are monocotyledonous plants.
- 56. The method of claim 55, wherein the monocotyledonous plants are selected from the group consisting of wheat, maize, rye, rice, turfgrass, oat, barley, sorghum, millet, and sugarcane.
- 57. A method of screening for a candidate GABA analog comprising the steps of:
a) obtaining a test plant; b) treating said test plant with a candidate GABA analog; and c) detecting the effect of said candidate GABA analog on the fertility of the test plant.
- 58. The method of claim 57, wherein detecting comprises detecting a decrease in the fertility of the plant.
- 59. The method of claim 57, wherein the test plant is a dioecious plant.
- 60. The method of claim 57, wherein the test plant is a monoecious plant.
- 61. The method of claim 57, wherein treating comprises applying the candidate GABA analog to a flower on the test plant.
- 62. A method of screening for a candidate GABA transaminase inhibitor comprising the steps of:
a) obtaining a test plant; b) treating said test plant with a candidate GABA transaminase inhibitor; and c) detecting the effect of said candidate GABA transaminase inhibitor on the fertility of the test plant.
- 63. The method of claim 62, wherein detecting comprises detecting a decrease in the fertility of the plant.
- 64. The method of claim 62, wherein the test plant is a dioecious plant.
- 65. The method of claim 62, wherein the test plant is a monoecious plant.
- 66. The method of claim 62, wherein treating comprises applying the candidate GABA transaminase inhibitor to a flower on the test plant.
- 67. The method of claim 62, wherein treating comprises applying the candidate GABA transaminase inhibitor over the top on the test plant.
- 68. A method of screening for a candidate GABA inhibitor comprising the steps of:
a) obtaining a test plant exhibiting decreased fertility as a result of elevated GABA levels; b) treating said test plant with a candidate GABA inhibitor; and c) detecting the effect of said candidate GABA inhibitor on the fertility of the test plant.
- 69. The method of claim 68, wherein the test plant comprises a mutation in the POP2 gene.
- 70. The method of claim 68, wherein the test plant comprises a transgenic POP2 gene.
- 71. The method of claim 68, wherein the test plant comprises an antisense POP2 gene.
- 72. The method of claim 68, wherein detecting comprises detecting a restoration of fertility following the treating.
Parent Case Info
[0001] This application claims the priority of U.S. Provisional Application Ser. No. 60/300,513, filed Jun. 22, 2001, the entire disclosure of which is specifically incorporated herein by reference. The government may own rights in this application pursuant to grant number DE-FG02-96ER20240 from the U.S. Department of Energy.